European Journal of Surgical Oncology
Volume 36, Issue 6 , Pages 511-513 , June 2010

Role of sentinel node biopsy in patients having neoadjuvant chemotherapy

  • J.M. Dixon

      Affiliations

    • Corresponding Author InformationCorresponding author. Research Office, Edinburgh Breast Unit, Western General Hospital, Edinburgh, EH4 2XU, Scotland, UK. Tel.: +44 131 537 2907; fax: +44 131 537 2653.

,Accepted 12 April 2010.

References 

  1. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. Journal of the National Cancer Institute. 2006;98(9):599–609
  2. Fringuelli FM, Lima G, Bottini A, Aguggini S, Allevia G, Bonardi S. Lymphoscintigraphy: the experience of the Cremona breast unit. Available from: http://2004.bucremona.org/index.aspx?m=53&did=25
  3. Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JN. Meta-analysis of sentinel node biopsy after preoperative chemotherapy in patients with breast cancer. British Journal of Surgery. 2006;93:539–546
  4. Fraile M, Rull M, Julian FJ, et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Annals of Oncology. 2000;11:701–705
  5. Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC. Meta-analysis of sentinel lymph node biopsy in breast cancer. Journal of Surgical Research. 1999;84:138–142
  6. Kim T, Agboola O, Lyman GH. Lymphatic mapping and sentinel lymph node sampling in breast cancer: a meta-analysis. 2002 ASCO Annual Meeting Proceedings, Orlando, Fl, 2002. Available from: http://www.asco.org.uk/ac/1, 1003,_12-002643-00-18-0016-00_19-00139, oo.asp
  7. van Deurzen CHM, Vriens BEPJ, Tjan-Heijnen VCG, et al. Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. European Journal of Cancer. 2009;45:3124–3130
  8. Kang SH, Kim SK, Kwon Y, et al. Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy. World Journal of Surgery. 2004;28:1019–1024
  9. Lee S, Kim EY, Kang SH, et al. Sentinel node identification rate but not accuracy is significantly decreased after preoperative chemotherapy in axillary node positive breast cancer patients. Breast Cancer Research and Treatment. 2007;102:283–288
  10. Jones JL, Zabicki K, Christina RL, et al. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. American Journal of Surgery. 2005;190:517–520
  11. Julian TB, Dusi D, Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. American Journal of Surgery. 2002;184:315–317
  12. Breslin TM, Cohen L, Sahin A, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. Journal of Clinical Oncology. 2000;18:3480–3486
  13. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National surgical adjuvant breast and bowel project B-18. Journal of Clinical Oncology. 1997;15:2483–2493
  14. Shimazu K, Tamaki Y, Taguchi T, Akazawa K, Unoue T, Noguchi S. Sentinel node lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma. Cancer. 2004;100:2555–2561
  15. Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Annals of Surgical Oncology. 2002;9:235–242
  16. Balch GC, Mithani SK, Richards KR, Beauchamp RD, Kelley MC. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Annals of Surgical Oncology. 2003;10:616–621
  17. Schwartz GF, Meltzer AJ. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast Journal. 2003;9:374–379
  18. Reitsamer R, Peintinger F, Rettenbacher L, Prokop E. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. Journal of Surgical Oncology. 2003;84:63–67
  19. Nason KS, Anderson Bo, Byrd DR, et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer. 2000;89:2187–2194
  20. Newman EA, Sabel MS, Nees AV, et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node positive breast cancer at presentation. Annals of Surgical Oncology. 2007;14:2946–2952
  21. Lang JE, Esserman LJ, Ewing CA, et al. Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. Journal of the American College of Surgeons. 2004;199:856–862
  22. Tausch C, Konstantiniuk P, Kugler F, et al., Austrian Sentinel Node Study Group  Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Annals of Surgical Oncology. 2006;15:3378–3383
  23. Mamounas EP, Brown A, Anderson S, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. Journal of Clinical Oncology. 2005;23:2694–2702
  24. Shen J, Gilcrease MZ, Babiera GV, et al. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer. 2007;109:1255–1263
  25. Gimbergues P, Abrial C, Durando X, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Annals of Surgical Oncology. 2008;15:1316–1321
  26. Hino M, Sano M, Sato N, Homma K. Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer. Surgery Today. 2008;38:585–591
  27. Kinoshita T. Sentinel lymph node biopsy is feasible for breast cancer patients after neoadjuvant chemotherapy. Breast Cancer. 2007;14:10–15
  28. Sabel MS, Schott AF, Kleer CG, et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. American Journal of Surgery. 2003;186:102–105
  29. Straver ME, Rutgers EJTh, Russell NS, et al. Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer. European Journal of Cancer. 2009;45:2284–2292
  30. Krag DN, Anderson SJ, Julian TB, et al., for the National Surgical Adjuvant Breast and Bowel Project (NSABP)  Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncology. 2007;8:881–888
  31. Kuehn T, Bauerfeind I, Fehm T, et al. SENTinel node biopsy before or after NeoAdjuvant systemic treatment: the German SENTINA trial. Cancer Research. 2009;69(Suppl. 2):Post No: 1008. Presented at 32nd San Antonio Breast Cancer Conference, December 2009. Available from: http://www.posters2view.com/sabcs09/lookup_view.php?word=Kuehn&where=authors&return=%2Fsabcs09%2Fauthorindex.php%3Fnum%3D10%26page%3D5%26start%3D156%26stop%3D39
  32. Dominici LS, Negron Gonzalez VM, Buzdar AU, et al. Eradication of axillary lymph node metastases occurs in 74% of patients receiving neoadjuvant chemotherapy with concurrent trastuzumab for HER2 positive breast cancer. Cancer Research. 2009;69(Suppl. 2):Poster No: 1086 Presented at 32nd San Antonio Breast Cancer Conference, December 2009. Available from: http://www.posters2view.com/sabcs09/lookup_view.php?word=Dominici&where=authors&return=%2Fsabcs09%2Fauthorindex.php%3Fnum%3D3%26page%3D5%26start%3D156%26stop%3D39

PII: S0748-7983(10)00097-1

doi: 10.1016/j.ejso.2010.04.009

European Journal of Surgical Oncology
Volume 36, Issue 6 , Pages 511-513 , June 2010

Article Tools